Cargando…

Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines

A549 human lung carcinoma cell lines were treated with a series of new drugs with both tacrine and coumarin pharmacophores (derivatives 1a–2c) in order to test the compounds’ ability to inhibit both cancer cell growth and topoisomerase I and II activity. The ability of human topoisomerase I (hTOPI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Konkoľová, Eva, Hudáčová, Monika, Hamuľaková, Slávka, Jendželovský, Rastislav, Vargová, Jana, Ševc, Juraj, Fedoročko, Peter, Kožurková, Mária
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924348/
https://www.ncbi.nlm.nih.gov/pubmed/33672694
http://dx.doi.org/10.3390/molecules26041133
_version_ 1783659069898227712
author Konkoľová, Eva
Hudáčová, Monika
Hamuľaková, Slávka
Jendželovský, Rastislav
Vargová, Jana
Ševc, Juraj
Fedoročko, Peter
Kožurková, Mária
author_facet Konkoľová, Eva
Hudáčová, Monika
Hamuľaková, Slávka
Jendželovský, Rastislav
Vargová, Jana
Ševc, Juraj
Fedoročko, Peter
Kožurková, Mária
author_sort Konkoľová, Eva
collection PubMed
description A549 human lung carcinoma cell lines were treated with a series of new drugs with both tacrine and coumarin pharmacophores (derivatives 1a–2c) in order to test the compounds’ ability to inhibit both cancer cell growth and topoisomerase I and II activity. The ability of human topoisomerase I (hTOPI) and II to relax supercoiled plasmid DNA in the presence of various concentrations of the tacrine-coumarin hybrid molecules was studied with agarose gel electrophoresis. The biological activities of the derivatives were studied using MTT assays, clonogenic assays, cell cycle analysis and quantification of cell number and viability. The content and localization of the derivatives in the cells were analysed using flow cytometry and confocal microscopy. All of the studied compounds were found to have inhibited topoisomerase I activity completely. The effect of the tacrine-coumarin hybrid compounds on cancer cells is likely to be dependent on the length of the chain between the tacrine and coumarin moieties (1c, 1d = tacrine-(CH(2))(8–9)-coumarin). The most active of the tested compounds, derivatives 1c and 1d, both display longer chains.
format Online
Article
Text
id pubmed-7924348
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79243482021-03-03 Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines Konkoľová, Eva Hudáčová, Monika Hamuľaková, Slávka Jendželovský, Rastislav Vargová, Jana Ševc, Juraj Fedoročko, Peter Kožurková, Mária Molecules Article A549 human lung carcinoma cell lines were treated with a series of new drugs with both tacrine and coumarin pharmacophores (derivatives 1a–2c) in order to test the compounds’ ability to inhibit both cancer cell growth and topoisomerase I and II activity. The ability of human topoisomerase I (hTOPI) and II to relax supercoiled plasmid DNA in the presence of various concentrations of the tacrine-coumarin hybrid molecules was studied with agarose gel electrophoresis. The biological activities of the derivatives were studied using MTT assays, clonogenic assays, cell cycle analysis and quantification of cell number and viability. The content and localization of the derivatives in the cells were analysed using flow cytometry and confocal microscopy. All of the studied compounds were found to have inhibited topoisomerase I activity completely. The effect of the tacrine-coumarin hybrid compounds on cancer cells is likely to be dependent on the length of the chain between the tacrine and coumarin moieties (1c, 1d = tacrine-(CH(2))(8–9)-coumarin). The most active of the tested compounds, derivatives 1c and 1d, both display longer chains. MDPI 2021-02-20 /pmc/articles/PMC7924348/ /pubmed/33672694 http://dx.doi.org/10.3390/molecules26041133 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Konkoľová, Eva
Hudáčová, Monika
Hamuľaková, Slávka
Jendželovský, Rastislav
Vargová, Jana
Ševc, Juraj
Fedoročko, Peter
Kožurková, Mária
Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines
title Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines
title_full Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines
title_fullStr Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines
title_full_unstemmed Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines
title_short Tacrine-Coumarin Derivatives as Topoisomerase Inhibitors with Antitumor Effects on A549 Human Lung Carcinoma Cancer Cell Lines
title_sort tacrine-coumarin derivatives as topoisomerase inhibitors with antitumor effects on a549 human lung carcinoma cancer cell lines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924348/
https://www.ncbi.nlm.nih.gov/pubmed/33672694
http://dx.doi.org/10.3390/molecules26041133
work_keys_str_mv AT konkolovaeva tacrinecoumarinderivativesastopoisomeraseinhibitorswithantitumoreffectsona549humanlungcarcinomacancercelllines
AT hudacovamonika tacrinecoumarinderivativesastopoisomeraseinhibitorswithantitumoreffectsona549humanlungcarcinomacancercelllines
AT hamulakovaslavka tacrinecoumarinderivativesastopoisomeraseinhibitorswithantitumoreffectsona549humanlungcarcinomacancercelllines
AT jendzelovskyrastislav tacrinecoumarinderivativesastopoisomeraseinhibitorswithantitumoreffectsona549humanlungcarcinomacancercelllines
AT vargovajana tacrinecoumarinderivativesastopoisomeraseinhibitorswithantitumoreffectsona549humanlungcarcinomacancercelllines
AT sevcjuraj tacrinecoumarinderivativesastopoisomeraseinhibitorswithantitumoreffectsona549humanlungcarcinomacancercelllines
AT fedorockopeter tacrinecoumarinderivativesastopoisomeraseinhibitorswithantitumoreffectsona549humanlungcarcinomacancercelllines
AT kozurkovamaria tacrinecoumarinderivativesastopoisomeraseinhibitorswithantitumoreffectsona549humanlungcarcinomacancercelllines